Axelopran for Advanced Cancer in Patients Receiving Opioids
Axelopran for Advanced Cancer in Patients Receiving Opioids
Recruiting · NCT07354919 · Registry updated 2026-05-05Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Axelopran for Advanced Cancer in Patients Receiving Opioids | Digestive System Diseases, Digestive System Neoplasms, Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Skin and Connective Tissue Diseases, Thoracic Neoplasms, Urogenital Diseases, Urogenital Neoplasms, breast cancer, breast disorder, breast neoplasm, endocrine system disorder, lung cancer, lung disorder, lung neoplasm, male reproductive organ cancer, male reproductive system disorder, malignant endocrine neoplasm, malignant pancreatic neoplasm, neoplasm, pancreas disorder, pancreatic neoplasm, prostate cancer, prostate disorder, respiratory system disorder, respiratory tract neoplasm, skin disorder | Recruiting | Phase 2 | 2026-05-05 | NCT07354919 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Glycyx MOR Inc. | 2 |
| HealthPartners Institute | 29 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| HealthPartners Cancer Center at Regions Hospital | Saint Paul | United States | 4 |
| HealthPartners Frauenshuh Cancer Research Center | Saint Louis Park | United States | 1 |